Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy
Sponsor: Sorrento Therapeutics, Inc.
Summary
Observational long-term follow-up study of patients who have been exposed to a gene-modified cell therapy produced by ex vivo transduction of immune cells expressing viral or non-viral vectors in studies sponsored by Sorrento Therapeutics, Inc.
Official title: Long-Term Follow-Up Study of Patients Who Have Received Gene-Modified Cell Therapy or Gene Therapy in Trials Sponsored By Sorrento Therapeutics, INC.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
1
Start Date
2021-06-16
Completion Date
2037-05
Last Updated
2023-01-23
Healthy Volunteers
No
Conditions
Interventions
Gene-Modified Cell Therapy
No investigational cell product will be administered
Locations (1)
Abramson Cancer Center Clinical Research Unit, University of Pennsylvania
Philadelphia, Pennsylvania, United States